Qiupei M. Liu
Ningbo, 315100, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Design, synthesis and pharmacological evaluation of 3H-spiro[benzofuran-2,4'-piperidine] IRAK4 inhibitors for the treatment of diffuse large B-cell lymphoma.
Journal: RSC medicinal chemistry
Published: January 12, 2026
Dual targeting of VEGFR2 and CSF1R with SYHA1813 confers novel strategy for treating both BRAF wild-type and mutant melanoma.
Journal: Cancer cell international
Published: March 31, 2025
Design and structural optimization of novel SOS1 inhibitors in KRAS-driven cancers.
Journal: Bioorganic & medicinal chemistry letters
Published: March 19, 2025
Discovery of a Covalent Inhibitor That Overcame Resistance to Venetoclax in AML Cells Overexpressing BFL-1.
Journal: Journal of medicinal chemistry
Published: June 24, 2024
A Novel IRAK4 Inhibitor DW18134 Ameliorates Peritonitis and Inflammatory Bowel Disease.
Journal: Molecules (Basel, Switzerland)
Published: March 16, 2024
Discovery of novel SOS1 inhibitors using machine learning.
Journal: RSC medicinal chemistry
Published: January 23, 2024
Branched-chain amino acid transaminase 1 confers EGFR-TKI resistance through epigenetic glycolytic activation.
Journal: Signal transduction and targeted therapy
Published: November 20, 2023
A novel strategy for treating oncogene-mutated tumors by targeting tumor microenvironment and synergistically enhancing anti-PD-1 immunotherapy.
Journal: Cancer communications (London, England)
Published: August 01, 2023
Pulmonary papillary adenoma: report of a case
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: December 08, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026